Dr. Ernest Fung is a board certified toxicologist with 10 years of professional experience in the areas of toxicology, pharmacology, and human health risk assessment. He received his M.S. in Pharmacology and Toxicology from the University of California, Irvine. His work during his master’s degree involved the discovery and development of a novel class of anti-inflammatory lipid mediators with expertise in dose response and structure activity relationships. Dr. Fung then completed his Ph.D. in Experimental Pathology at the University of California, Irvine. His doctoral work focused on neurodevelopmental pathology on embryonic forebrain development. As a consultant, Dr. Fung’s primary areas of practice include personal care and consumer products, medical devices, active pharmaceutical ingredients, and electronic cigarette safety. He has led multiple efforts related to understanding the toxicology and potential risk to human health in these areas. Dr. Fung has published over 70 abstracts and peer-reviewed publications on various toxicology, environmental, occupational, and risk assessment-related topics.


  • Ph.D., Experimental Pathology, University of California, Irvine, 2014
  • M.S., Pharmacology and Toxicology, University of California, Irvine, 2011
  • B.S., Biochemistry and Molecular Biology, The Pennsylvania State University, 2006

Professional Associations

  • Society for Neuroscience – Student member (2011-2014)
  • Society of Toxicology – Full member (since 2014)
  • International Society for Pharmaceutical Engineering – Associate member (since 2018)


  • Diplomate of the American Board of Toxicology (DABT) (since 2018)

Most Recent Awards/Professional Honors

  • Opportunity Award Grant, Center for Complex Biological Systems, University of California, Irvine, 2011
  • Best Published Paper Award in the Medical Device and Combination Product Specialty Section, Society of Toxicology, 2017